Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

What Analysts Are Saying About Humana Stock May 01, 2025 — 06:01 pm EDT. ... Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December, 2024.

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

It’s a significant loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

This was the stock's second consecutive day of losses.

This stock's P/B looks attractive against its industry's average P/B of 2.20. Within the past 52 weeks, HUM's P/B has been as high as 2.91 and as low as 1.52, with a median of 1.93. Value ...

This was the stock's fourth consecutive day of losses.

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

Valued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and specialty insurance products. Operating through its Insurance and CenterWell ...